Lodo Therapeutics Corp.

Industry

  • Digital Health
    • Artificial Intelligence
  • Biotechnology
    • Drug Discovery Technologies
      • Genomics-Proteomics
      • Bioinformatics
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals

Other Names/Subsidiaries

  • Conifer Point Pharmaceuticals, LLC
  • Hibiskus Biopharma, Inc.
See more in Biomedtracker

Latest on Lodo Therapeutics Corp.

Scrip

Deal Watch: AbbVie To Try Caraway’s Lysosomal Function Approach To Parkinson’s

 
• By Joseph Haas

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. AbbVie, Caraway Research Targets TMEM17

Scrip

Deal Watch: Bausch Health Takes Option To Allegro Dry AMD Candidate

 
• By Joseph Haas, Alex Shimmings, and Brian Yang

Scrip regularly covers business development and deal-making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Bausch Makes $50m Commitment For Risute

Scrip

Start-Up Quarterly Statistics: A Record-Breaking Q2 As Financings Surge

 
• By Deanna Kamienski

The second quarter was a record-breaking period with China-focused biopharma start-ups and others raising hundreds of millions of dollars in venture capital. Both the amount of money raised and the nu

Scrip

Genentech Mines The Microbiome Again With IBD Deal

 
• By Jo Shorthouse

Microbiotica Ltd. , a spin out from the Wellcome Trust Sanger Institute, will use its metagenomics microbiome platform to analyse data from Genentech Inc. ’s inflammatory bowel disease (IBD) trials t